Virtual care use during the COVID-19 pandemic and its impact on healthcare utilization in patients with chronic disease: a population-based repeated cross-sectional study V Stamenova, C Chu, A Pang, J Fang, A Shakeri, P Cram, ... PloS one 17 (4), e0267218, 2022 | 50 | 2022 |
Romosozumab (sclerostin monoclonal antibody) for the treatment of osteoporosis in postmenopausal women: A review A Shakeri, C Adanty Journal of population therapeutics and clinical pharmacology= Journal de la …, 2020 | 45 | 2020 |
Assessment of stimulant use and cardiovascular event risks among older adults M Tadrous, A Shakeri, C Chu, J Watt, MM Mamdani, DN Juurlink, ... JAMA network open 4 (10), e2130795-e2130795, 2021 | 30 | 2021 |
Spending on hepatitis C antivirals in the United States and Canada, 2014 to 2018 A Shakeri, N Srimurugathasan, KJ Suda, T Gomes, M Tadrous Value in Health 23 (9), 1137-1141, 2020 | 19 | 2020 |
Global Utilization trends of Direct Acting Antivirals (DAAs) during the COVID-19 pandemic: a time series analysis A Shakeri, N Konstantelos, C Chu, T Antoniou, J Feld, KJ Suda, ... Viruses 13 (7), 1314, 2021 | 18 | 2021 |
Canadian trends and projections in prescription drug purchases: 2001–2023 M Tadrous, A Shakeri, KN Hayes, HL Neville, J Houlihan, F Clement, ... Canadian Journal of Health Technologies 1 (11), 2021 | 14 | 2021 |
Impact of the 2016 policy change on the delivery of MedsCheck services in Ontario: an interrupted time-series analysis A Shakeri, L Dolovich, L MacCallum, JM Gamble, L Zhou, SM Cadarette Pharmacy 7 (3), 115, 2019 | 12 | 2019 |
Impact of COVID-19 on prescribing trends of direct-acting antivirals for the treatment of hepatitis C in Ontario, Canada N Konstantelos, A Shakeri, D McCormack, JJ Feld, T Gomes, M Tadrous Official journal of the American College of Gastroenterology| ACG 116 (8 …, 2021 | 9 | 2021 |
New-generation antiepileptic drugs during pregnancy and the risk of attention-deficit hyperactivity disorder: A scoping review. C Vaccaro, A Shakeri, E Czaplinski, S Eltonsy Journal of Population Therapeutics and Clinical Pharmacology= Journal de la …, 2020 | 9 | 2020 |
Comparison of healthcare utilization between telemedicine and standard care: a propensity-score matched cohort study among individuals with chronic psychotic disorders in … A Shakeri, C Chu, V Stamenova, J Fang, LC Barker, SN Vigod, RS Bhatia, ... Schizophrenia bulletin open 3 (1), sgac046, 2022 | 7 | 2022 |
Comparison of public and private payments for direct-acting antivirals (DAAs) across Canada A Shakeri, KN Hayes, T Gomes, M Tadrous Canadian Liver Journal 4 (4), 426-429, 2021 | 7 | 2021 |
Childhood trauma exposure and personality traits in schizophrenia patients C Adanty, J Qian, Y Wang, G Remington, A Shakeri, C Borlido, ... Schizophrenia Research 241, 221-227, 2022 | 6 | 2022 |
Regional differences in access to direct-acting antiviral treatments for hepatitis C across Ontario: A cross-sectional study N Konstantelos, A Shakeri, D McCormack, A Campos-Meade, T Gomes, ... Canada Communicable Disease Report 48 (4), 179, 2022 | 4 | 2022 |
Choppy waters: The importance of accounting for shifting drug utilization during the COVID‐19 pandemic in future observational drug‐related studies A Shakeri, T Gomes, K Suda, M Tadrous Basic & Clinical Pharmacology & Toxicology 128 (5), 649, 2021 | 4 | 2021 |
Defining donation A Shakeri, H Kugathasan Hektoen Int. J. Med. Humanit 12, 2020 | 4 | 2020 |
The Ontario Pharmacy Evidence Network Atlas of MedsCheck services Q Gan, AS Loi, M Chaudhry, N He, A Shakeri, L Dolovich, SM Cadarette Canadian Pharmacists Journal/Revue des Pharmaciens du Canada 155 (3), 151-156, 2022 | 3 | 2022 |
Head-to-head comparison of various antipsychotic agents on genome-wide methylation in schizophrenia C Adanty, A Shakeri, J Strauss, A Graff, V De Luca Pharmacogenomics 23 (1), 5-14, 2022 | 3 | 2022 |
The missed opportunity for real‐world evidence to shape our understanding of medical cannabis. A Shakeri, M Zhang, M Tadrous British Journal of Clinical Pharmacology 87 (3), 2021 | 3 | 2021 |
The association between telemedicine use and changes in health care usage and outcomes in patients with congestive heart failure: retrospective cohort study C Chu, V Stamenova, J Fang, A Shakeri, M Tadrous, RS Bhatia JMIR cardio 6 (2), e36442, 2022 | 2 | 2022 |
Impact of the October 2016 policy change on the delivery of MedsCheck annual and MedsCheck diabetes services in Ontario community pharmacies A Shakeri, L Dolovich, L MacCallum, JM Gamble, L Zhou, SM Cadarette Pharmacoepidemiology and Drug Safety 28, 528-528, 2019 | 1 | 2019 |